Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia
Oncotarget | May 31, 2016 | Volume: 7 | Issue: 27 | Pages: 41825-41842
10.18632/oncotarget.9729
| PMID 27259232